ARTICLE | Company News
Invitrogen, University of Queensland, Pamgene sales and marketing update
January 21, 2008 8:00 AM UTC
Invitrogen and PamGene will co-market Invitrogen's nuclear hormone receptor proteins and Lanthascreen assay technology with PamGene's microarray-based nuclear hormone receptor screening tools. ...